StockNews.com Begins Coverage on Mannatech (NASDAQ:MTEX)

StockNews.com started coverage on shares of Mannatech (NASDAQ:MTEX) in a research note issued to investors on Wednesday. The firm issued a buy rating on the stock.

Mannatech Stock Up 2.7 %

NASDAQ:MTEX opened at $7.70 on Wednesday. The company’s 50-day simple moving average is $7.45 and its 200-day simple moving average is $7.62. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.62 and a current ratio of 1.17. Mannatech has a fifty-two week low of $6.75 and a fifty-two week high of $10.51. The stock has a market capitalization of $14.51 million, a P/E ratio of -8.65 and a beta of 1.17.

Mannatech (NASDAQ:MTEX) last announced its earnings results on Tuesday, August 13th. The company reported ($0.33) earnings per share for the quarter. The firm had revenue of $27.74 million during the quarter. Mannatech had a negative net margin of 0.97% and a negative return on equity of 11.87%.

Insider Activity at Mannatech

In other news, Director Larry A. Jobe sold 16,288 shares of the stock in a transaction dated Monday, September 9th. The stock was sold at an average price of $7.75, for a total value of $126,232.00. Following the transaction, the director now directly owns 54,721 shares of the company’s stock, valued at approximately $424,087.75. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 41.50% of the stock is owned by insiders.

Mannatech Company Profile

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.